Men’s Health Brand Gets Big Surprise

Durham, NC (PRWEB) 11 September 2012 A new study by Phoenix Healthcare, a division of Phoenix Marketing International has found that half (47%) of me...


Durham, NC (PRWEB) 11 September 2012

A new study by Phoenix Healthcare, a division of Phoenix Marketing International has found that half (47%) of men suffering 45 + from several mens health conditions known primarily by their abbreviations ED, BPH, Low T and gout. This market mixed morbidity is greater than one of these conditions individually. With over 30 million people today (and 14% growth in 2020 and 27% by 2030), it is no wonder, pharmaceuticals competition heats up quickly for Men attention about their conditions and their brands to learn.

Seventeen (17) ED, BPH, gout or Low T DTC advertising brands jumped by 33% to over $ 400 million dollars. This is very rare growth in DTC. To see if that kind of money led to more men to talk with their doctors, Phoenix surveyed a large sample of 1,500 people, 45 +. And what they discovered was surprising.

Only 1 in 10 men (13%) who talked to their doctor about their mixed gout symptoms talked about their gout. This is in stark contrast to the 8 out of 10 men (76%) mixed with gout symptoms gout treatment Takeda ads or Ulorics observed green bottle ads. Despite gout symptoms, it was their symptoms of ED, Low T then BPH, which won the largest share of the symptoms discussion. Obviously, the battle for market growth by competition for share of voice is fueled in the doctor’s office.

Phoenix Healthcare led the 360? MarketView brand and ad tracking method in response to rapid changes in the 21st Century pharmaceutical consumer marketing. With the aim of reducing the cost of network television, many began experimenting with various pharmaceuticals integrated media strategies with the search, interactive banners, viral media (eg YouTube), social media, and even mobile marketing. Viagra see innovative use of a YouTube channel and Abbott’s good is it Low T commercial poaching to a possible gout discussion and, in return, to discuss the terms of their brands helped treat.

Phoenix Healthcare 360? MarketView studies currently cover 40% of all DTC spending in the United States with the research in the following categories: dyslipidemia, contraceptives, schizophrenia, rheumatoid arthritis, plaque psoriasis, Crohn’s disease, psoriatic arthritis, ankylosing spondylitis, and Men’s Health. Pursues a partial list of the most important brands in these programs include: Abilify, Actemra, AndroGel, Cialis, Cimzia, Colcrys, Ella, Enbrel, Essure, Fanapt, Generess FE, Humira, Invega Sustenna, Januvia, Levitra, Lo Loestrin FE, Mirena, Niaspan, Orencia, Ortho Tricyclic Lo, ParaGard, Plan B, Rapiflo, Remicade, Rituxan, Seroquel XR, Simponi, Stelara, Uloric, Viagra, Victoza and Zyprexa Relprevv.

Mens Health Study report on your particular category is available for free. If you are interested in this report, or have questions about a program specifically for your brand, please contact John Duggan at 508-315-6184.


Leave a Reply